Characteristics of the study population and matched comparator group (controls) at baseline
| Global | Cases | Controls | p | |
|---|---|---|---|---|
| N = 460 | N = 92 | N = 368 | ||
| Sex | 1.000 | |||
| Men | 215 (46.7%) | 43 (46.7%) | 172 (46.7%) | |
| Women | 245 (53.3%) | 49 (53.3%) | 196 (53.3%) | |
| Age (years), mean (DS) | 77.2 (9.56) | 77.0 (9.75) | 77.3 (9.52) | 0.764 |
| Yearly income | 0.266 | |||
| Moderate-high (>18,000€) | 140 (30.4%) | 27 (29.3%) | 113 (30.7%) | |
| Low (<18,000 €) | 307 (66.7%) | 60 (65.2%) | 247 (67.1%) | |
| Very low (social income) | 13 (2.83%) | 5 (5.43%) | 8 (2.17%) | |
| Morbidity at discharge | ||||
| Health risk (GMA index) | 19.9 (13.6) | 19.9 (13.1) | 19.9 (13.8) | 0.998 |
| GMA group | 1.000 | |||
| Very low risk | 80 (17.4%) | 16 (17.4%) | 64 (17.4%) | |
| Low risk | 145 (31.5%) | 29 (31.5%) | 116 (31.5%) | |
| Moderate risk | 100 (21.7%) | 20 (21.7%) | 80 (21.7%) | |
| High risk | 55 (12.0%) | 11 (12.0%) | 44 (12.0%) | |
| Very high risk | 80 (17.4%) | 16 (17.4%) | 64 (17.4%) | |
| Type of stroke | 0.009 | |||
| Hemorrhagic | 82 (17.8%) | 18 (19.6%) | 64 (17.4%) | |
| Ischemic | 375 (81.5%) | 71 (77.2%) | 304 (82.6%) | |
| Other | 3 (0.65%) | 3 (3.26%) | 0 (0.00%) | |
| Admission to skilled nursing facility on discharge | 0.050 | |||
| No | 293 (63.7%) | 50 (54.3%) | 243 (66.0%) | |
| Yes | 167 (36.3%) | 42 (45.7%) | 125 (34.0%) | |
| Global expenditure within the year preceding the stroke episode (€), mean [median] | ||||
| Outpatient services | 915 [674] | 884 [692] | 923 [667] | 0.899 |
| Inpatient services | 1,633 [0] | 1,537 [0] | 1,657 [0] | 0.130 |
| Pharmaceutical expenditure | 908 [385] | 630 [278] | 977 [396] | 0.072 |
| Other healthcare services | 121 [0] | 334 [0] | 68 [0] | 0.978 |
| Total healthcare expenditure | 3,576 [1,508] | 3,385 [1,497] | 3,624 [1,508] | 0.943 |
| Global | Cases | Controls | ||
|---|---|---|---|---|
| 1.000 | ||||
| Men | 215 (46.7%) | 43 (46.7%) | 172 (46.7%) | |
| Women | 245 (53.3%) | 49 (53.3%) | 196 (53.3%) | |
| 77.2 (9.56) | 77.0 (9.75) | 77.3 (9.52) | 0.764 | |
| 0.266 | ||||
| Moderate-high (>18,000€) | 140 (30.4%) | 27 (29.3%) | 113 (30.7%) | |
| Low (<18,000 €) | 307 (66.7%) | 60 (65.2%) | 247 (67.1%) | |
| Very low (social income) | 13 (2.83%) | 5 (5.43%) | 8 (2.17%) | |
| 19.9 (13.6) | 19.9 (13.1) | 19.9 (13.8) | 0.998 | |
| 1.000 | ||||
| Very low risk | 80 (17.4%) | 16 (17.4%) | 64 (17.4%) | |
| Low risk | 145 (31.5%) | 29 (31.5%) | 116 (31.5%) | |
| Moderate risk | 100 (21.7%) | 20 (21.7%) | 80 (21.7%) | |
| High risk | 55 (12.0%) | 11 (12.0%) | 44 (12.0%) | |
| Very high risk | 80 (17.4%) | 16 (17.4%) | 64 (17.4%) | |
| 0.009 | ||||
| Hemorrhagic | 82 (17.8%) | 18 (19.6%) | 64 (17.4%) | |
| Ischemic | 375 (81.5%) | 71 (77.2%) | 304 (82.6%) | |
| Other | 3 (0.65%) | 3 (3.26%) | 0 (0.00%) | |
| 0.050 | ||||
| No | 293 (63.7%) | 50 (54.3%) | 243 (66.0%) | |
| Yes | 167 (36.3%) | 42 (45.7%) | 125 (34.0%) | |
| Outpatient services | 915 [674] | 884 [692] | 923 [667] | 0.899 |
| Inpatient services | 1,633 [0] | 1,537 [0] | 1,657 [0] | 0.130 |
| Pharmaceutical expenditure | 908 [385] | 630 [278] | 977 [396] | 0.072 |
| Other healthcare services | 121 [0] | 334 [0] | 68 [0] | 0.978 |
| Total healthcare expenditure | 3,576 [1,508] | 3,385 [1,497] | 3,624 [1,508] | 0.943 |
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.